LAUREN ISBELL: Open Payments
NPI 1912240425 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 33 payments from 13 companies in 2025. Trend: 2023 $610 · 2024 $810 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 12 | $171 |
| ABBVIE INC. | 5 | $104 |
| Vanda Pharmaceuticals Inc. | 3 | $43 |
| JAZZ PHARMACEUTICALS INC. | 1 | $39 |
| Lundbeck LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Corium, LLC | 1 | $22 |
Products named: APLENZIN, VRAYLAR, XYWAV, REXULTI, Auvelity, Qelbree, HETLIOZ, INGREZZA.
Industry payments across NC — which companies pay providers there.
